Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Do Not Let to Be Late: Overview of Reasons for Melanoma Delayed Diagnosis

  • Published : 2014.05.15
Download PDF
⟨ Previous Next ⟩

Abstract

Melanoma of the skin is a malignant tumor, which incidence is still increasing. It was estimated that in the United States one person died from this cause every hour. The major risk factor of this disease is exposure to ultraviolet radiation, especially associated with the occurrence of sunburns. Patients diagnosed with distant metastases have median survival of 6-9 months. The aim of this paper was to identify the causes of delayed diagnosis of melanoma as diagnosis at an early stage seems to be the key to improve the survival rates. For this purpose, a search of medical databases such as PubMed, Google Scholar and Cancer Registers was conducted and an analysis of the literature from the years 1979-2013 was conducted.

Keywords

References

  1. Al-Naggar RA, Al-Naggar TH, Bobryshev YV (2011). Perceptions and opinions towards skin cancer prevention in Malaysia: A Qualitative approach. Asian Pac Cancer Prev, 12, 995-9.
  2. Alexandrescu DT (2009). Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages. Dermatol Online J, 15, 1.
  3. American Cancer Society (2013). Cancer Facts & Figures 2013. Available from: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf, accessed on 23.11.2013.
  4. Andsoy II, Gul A, Sahin AO, Karabacak H (2013). What turkish nurses know and do about skin cancer and sun protective behavior. Asian Pac J Cancer Prev, 14, 7663-8. https://doi.org/10.7314/APJCP.2013.14.12.7663
  5. Baade PD, English DR, Youl PH et al (2006). The relationship between melanoma thickness and time to diagnosis in a large population-based study. Arch Dermatol, 142, 1422-7.
  6. Balch CM, Gershenwald JE, Soong SJ, et al (2009). Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol, 27, 6199-206. https://doi.org/10.1200/JCO.2009.23.4799
  7. Betti R, Vergani R, Tolomio E, Santambrogio R, Crosti C (2003). Factors of delay in the diagnosis of melanoma. Eur J Dermatol, 13, 183-8.
  8. Byrd KM, Wilson DC, Hoyler SS, Peck GL (2004). Advanced presentation of melanoma in African Americans. J Am Acad Dermatol, 50, 21-4. https://doi.org/10.1016/S0190-9622(03)02091-7
  9. Ferlay J, Soerjomataram I, Ervik M, et al (2013). GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on 12.04.2014.
  10. Forsea AM, Del Marmol V, de Vries E, Bailey EE, Geller AC (2012). Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol, 167, 1124-30. https://doi.org/10.1111/j.1365-2133.2012.11125.x
  11. Giacomel J, Zalaudek I, Mordente I, Nicolino R, Argenziano G (2008). Never perform laser treatment of skin tumors with clinical "EFG" criteria. J Dtsch Dermatol Ges, 6, 386-8. https://doi.org/10.1111/j.1610-0387.2007.06592.x
  12. Grann AF, Froslev T, Olesen AB, Schmidt H, Lash TL (2013). The impact of comorbidity and stage on prognosis of Danish melanoma patients, 1987-2009: a registry-based cohort study. Br J Cancer, 109, 265-71. https://doi.org/10.1038/bjc.2013.246
  13. Houghton AN, Polsky D (2002). Focus on melanoma. Cancer Cell, 2, 275-8. https://doi.org/10.1016/S1535-6108(02)00161-7
  14. Hu S, Soza-Vento RM, Parker DF, Kirsner RS (2006). Comparison of stage at diagnosis of melanoma among hispanic, black, and white patients in miami-dade county, Florida. Arch Dermatol, 142, 704-8.
  15. Kang JC, Wanek LA, Essner R, et al (2005). Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma. J Clin Oncol, 23, 4764-70. https://doi.org/10.1200/JCO.2005.20.537
  16. Karabeg R, Lukic D, Janjic Z, et al (2012). The analysis of reasons for malignant skin tumors late diagnosis. Mater Sociomed, 24, 73-5. https://doi.org/10.5455/msm.2012.24.73-75
  17. Krige JE, Isaacs S, Hudson DA, et al (1991). Delay in the diagnosis of cutaneous malignant melanoma. A prospective study in 250 patients. Cancer, 68, 2064-8. https://doi.org/10.1002/1097-0142(19911101)68:9<2064::AID-CNCR2820680937>3.0.CO;2-3
  18. Kycler W, Grodecka-Gazdecka S, Breborowicz J, Filas V, Teresiak M (2002). Prognostic value of selected immunohistochemical markers in skin melanoma. Nowotwory, 6, 487-95.
  19. Lee HY, Chay WY, Tang MB, Chio MT, Tan SH (2012). Melanoma: differences between Asian and Caucasian patients. Ann Acad Med Singapore, 41, 17-20.
  20. Liang JJ, Robinson E, Martin RC (2010). Cutaneous melanoma in New Zealand: 2000-2004. ANZ J Surg, 80, 312-6. https://doi.org/10.1111/j.1445-2197.2009.05199.x
  21. Lin JS, Eder M, Weinmann S (2011). Behavioral counseling to prevent skin cancer: asystematic review for the U.S. preventive services task force. Ann Intern Med, 154, 190-201. https://doi.org/10.7326/0003-4819-154-3-201102010-00009
  22. Malak AT, Yildirim P, Yildiz Z, Bekta. M (2013). Effects of training about skin cancer on farmers' knowledge level and attitudes. Asian Pac J Cancer Prev, 12, 117-20.
  23. Matzke TJ, Andrew K, Bean AK, Ackerman T (2009). Avoiding delayed diagnosis of malignant melanoma. J Nurse Pract, 5, 42-6. https://doi.org/10.1016/j.nurpra.2008.08.019
  24. McLaughlin JM, Fisher JL, Paskett ED (2011). Marital status and stage at diagnosis of cutaneous melanoma: results from the surveillance epidemiology and end results (SEER) program, 1973-2006. Cancer, 117, 1984-93. https://doi.org/10.1002/cncr.25726
  25. Pipitone M, Robinson JK, Camara C, Chittineni B, Fisher SG (2002). Skin cancer awareness in suburban employees: a Hispanic perspective. J Am Acad Dermatol, 47, 118-23. https://doi.org/10.1067/mjd.2002.120450
  26. Reed KB, Brewer JD, Lohse CM, et al (2012). Increasing incidence of melanoma among young adults: an epidemiological study in olmsted county, minnesota. Mayo Clin Proc, 87, 328-34. https://doi.org/10.1016/j.mayocp.2012.01.010
  27. Richard MA, Grob JJ, Avril MF, et al (2000b): Delays in diagnosis and melanoma prognosis: the role of patients. Int J Cancer, 89, 271-9. https://doi.org/10.1002/1097-0215(20000520)89:3<271::AID-IJC10>3.0.CO;2-7
  28. Richard MA, Grob JJ, Avril MF, et al (2000a). Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer, 89, 280-5. https://doi.org/10.1002/1097-0215(20000520)89:3<280::AID-IJC11>3.0.CO;2-2
  29. Rigel DS, Friedman RJ, Kopf AW, Polsky D (2005). ABCDE -an evolving concept in the early detection of melanoma. Arch Dermatol, 141, 1032-4.
  30. Saraiya M, Hall HI, Thompson T, et al (2004). Skin cancer screening among U.S. adults from 1992, 1998, and 2000 national health interview surveys. Prev Med, 39, 308-14. https://doi.org/10.1016/j.ypmed.2004.04.022
  31. Schmid-Wendtner MH, Baumert J, Stange J, Volkenandt M (2002). Delay in the diagnosis of cutaneous melanoma: an analysis of 233 patients. Melanoma Res, 12, 389-94. https://doi.org/10.1097/00008390-200208000-00012
  32. Smith T (1979). The Queensland Melanoma Project--an exercise in health education. Br Med J, 1, 253-4. https://doi.org/10.1136/bmj.1.6158.253
  33. Szczurkowska P, Ornowska M, Sobjanek M, et al (2012). Cutaneous melanoma . clinicopathological analysis of 128 patients from Northern Polish population. Clin Dermatol, 14, 122-6.
  34. Szkultecka-Debek M, Lugowska I, Sozanska-Solak A, et al (2012). Stage III/IV melanoma in Poland: epidemiology, standard of care and treatment related costs. JPHOR, 2, 41-7.
  35. Temoshok L, DiClemente RJ, Sweet DM, Blois MS, Sagebiel RW (1984). Factors related to patient delay in seeking medical attention for cutaneous malignant melanoma. Cancer, 54, 3048-53. https://doi.org/10.1002/1097-0142(19841215)54:12<3048::AID-CNCR2820541239>3.0.CO;2-M
  36. The Centers for Disease Control and Prevention. CDC 24/7: Saving life. Protecting people. (2012). Skin Cancer. Skin Cancer Rates by Race and Ethnicity. Available from: http://www.cdc.gov/cancer/skin/statistics/race.htm, accessed on 14.04.2014.
  37. Zalaudek I, Argenziano G, Soyer HP, et al (2006). Dermoscopy Working Group. Three-point checklist of dermoscopy: an open internet study. Br J Dermatol, 154, 431-7. https://doi.org/10.1111/j.1365-2133.2005.06983.x

Cited by

  1. A Retrospective Multicenter Evaluation of Cutaneous Melanomas in Turkey vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10451
  2. Eyelid Tumors: Clinical Data from an Eye Center in Ankara, Turkey vol.16, pp.10, 2015, https://doi.org/10.7314/APJCP.2015.16.10.4265
  3. Treatment Outcome and Prognostic Factors for Malignant Skin Melanoma Treated with Radical Surgery vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5709
  4. Sun Burn Incidence and Knowledge of Greek Elementary and High School Children about Sun Protection vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1529
  5. Public Awareness of Warning Signs and Symptoms of Cancer in Oman: A Community-Based Survey of Adults vol.16, pp.7, 2015, https://doi.org/10.7314/APJCP.2015.16.7.2731
  6. What Do Web Users Know about Skin Self-Examination and Melanoma Symptoms? vol.16, pp.7, 2015, https://doi.org/10.7314/APJCP.2015.16.7.3051
  7. Standardization of A375 human melanoma models on chicken embryo chorioallantoic membrane and Balb/c nude mice vol.38, pp.1, 2017, https://doi.org/10.3892/or.2017.5658
  8. Cancer awareness among community pharmacist: a systematic review vol.18, pp.1, 2018, https://doi.org/10.1186/s12885-018-4195-y